Doping and drug testing: Anti-doping work must be transparent and adhere to good scientific practices to ensure public trust.
Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.|Department of Biosciences, University of Oslo, Oslo, Norway.
Erik
E
Boye
Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.|Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Tore
T
Skotland
Institute for Medical Biology, UiT, The Norwegian Arctic University, Tromsø, Norway.
Bjarne
B
Østerud
Department of Biosciences, University of Oslo, Oslo, Norway.
Jon
J
Nissen-Meyer
D000328:Adult; D056352:Athletes; D002623:Chemistry Techniques, Analytical / Q000941:ethics* / Q000295:instrumentation / Q000592:standards; D004300:Doping in Sports / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D015813:Substance Abuse Detection / Q000941:ethics* / Q000295:instrumentation / Q000379:methods; D035502:Trust